Inactive Instrument

VIVO Cannabis Inc.

VIVO

CA92845J1049

Aaron Keay Do Not Stand for Re-Election as Director of Vivo Cannabis Inc

June 05, 2019 at 01:00 pm EDT

Aaron Keay did not stand for re-election at the Meeting and ceased to be a director of VIVO Cannabis Inc. effective June 4, 2019.

Latest news about VIVO Cannabis Inc.

MediPharm Labs Corp. Brief: Combined Company is owned approximately 73.1% by former MediPharm shareholders and approximately 26.9% by former VIVO shareholders	23-04-03	MT
MediPharm Labs Corp. Brief: Says Completed Acquisition of VIVO Cannabis Inc. and Confirmed Final Ownership Ratio	23-04-03	MT
MediPharm Labs Corp. completed the acquisition of VIVO Cannabis Inc. from directors and officers of VIVO and others.	23-03-31	CI
VIVO Cannabis Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-28	CI
VIVO Cannabis Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-28	CI
Transcript : VIVO Cannabis Inc. - Shareholder/Analyst Call	23-03-21
MediPharm Labs Rises 7% As Says To Acquire VIVO Cannabis In All-Share Deal	22-12-22	MT
MediPharm Labs To Acquire VIVO Cannabis In All-Share Deal	22-12-22	MT
MediPharm Labs Corp. entered into a definitive arrangement agreement to acquire VIVO Cannabis Inc. from directors and officers of VIVO and others for CAD 11.2 million.	22-12-21	CI
VIVO Cannabis Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-13	CI
VIVO Cannabis Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15	CI
VIVO Cannabis Up 10% after Reporting Research Licence for Canna Farms by Health Canada	22-07-22	MT
Transcript : VIVO Cannabis Inc. - Shareholder/Analyst Call	22-06-30
VIVO Cannabis Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-15	CI
VIVO Cannabis Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-31	CI
VIVO Cannabis Inc. Auditor Raises 'Going Concern' Doubt	22-03-30	CI
VIVO Cannabis Inc. Announces Directorate Changes	21-12-21	CI
Vivo Cannabis Announces Launch of Beacon Medical(TM) High-Dose CBD Oil and Pediatric Compassionate Care Program	21-11-23	CI
Transcript : VIVO Cannabis Inc., Q3 2021 Pre Recorded Earnings Call, Nov 15, 2021	21-11-14
VIVO Cannabis Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-14	CI
Transcript : VIVO Cannabis Inc., Q2 2021 Pre Recorded Earnings Call, Aug 17, 2021	21-08-16
VIVO Cannabis Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-15	CI
VIVO Cannabis Launches Canna Farms Brick Hash and Large Format Pink Kush Flower to Online Medical Marketplace	21-07-22	CI
Transcript : VIVO Cannabis Inc. - Shareholder/Analyst Call	21-07-05
VIVO Cannabis Inc. Announces Board Resignations	21-07-05	CI

Vivo Cannabis Inc is a Canada-based company that provides cannabis products and services. The Company's principal business activity is the production and sale of medical and adult-use cannabis and cannabis products and providing cannabis-related medical information and services in Canada. The Company has a range of of premium brands, each targeting different customer segments, including Canna Farms, Beacon Medical, Fireside, and Lumina. Harvest Medicine, the Company's patient-centric network of medical cannabis clinics. The Company holds production and sales licenses from Health Canada and operates indoor and seasonal airhouse cultivation facilities. It offers pharmaceutical-grade products grown in small batches in Napanee, Ontario. Its Beacon Cannabis provides navigating medical cannabis using the Beacon Cannatypes classification system. The Company's wholly owned subsidiaries include ABcann Medicinals Inc (ABcann) and Canna Farms Limited (Canna Farms).

Sector

Pharmaceuticals

More about the company

Sector Alternative Medicine

	1st Jan change	Capi.
DONG-E-E-JIAO CO.,LTD.	+41.06%	6.26B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-15.95%	4.49B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+6.36%	3.29B
TASLY PHARMACEUTICAL GROUP CO., LTD	-11.34%	3.12B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-3.12%	2.5B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+45.41%	1.94B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-7.74%	1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-0.67%	1.63B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-11.32%	1.56B

Alternative Medicine